Understanding The Potential of WDR97 as A Drug Target and Biomarker

Target Name: WDR97

NCBI ID: G340390

WDR97

Other Name(s): KIAA1875 | WD repeat domain 97

Understanding The Potential of WDR97 as A Drug Target and Biomarker

WDR97 (KIAA1875) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and function have made it an attractive target for researchers to study.

WDR97 is a RNA molecule that is found in most tissues of the body. It is composed of 71 amino acid residues and has a molecular weight of 187.5 kDa. The RNA molecule is predominantly expressed in the brain and is also found in other tissues such as the heart, lungs, and kidneys.

WDR97 has been shown to play a role in various physiological processes in the body. One of its well-known functions is its role in the regulation of stem cell proliferation. Studies have shown that WDR97 can induce stem cells to differentiate into functional neurons that are capable of transmitting electrical signals.

WDR97 has also been shown to play a role in the regulation of neurotransmitter release from nerve cells. Studies have shown that when WDR97 is activated, it can cause the release of neurotransmitters such as dopamine and serotonin from nerve cells.

WDR97 has also been shown to be involved in the regulation of inflammation. Studies have shown that WDR97 can cause inflammation to start and persist in the body. This is important because chronic inflammation is associated with a number of diseases, including heart disease, cancer, and neurodegenerative diseases.

WDR97 has also been shown to play a role in the regulation of protein synthesis. Studies have shown that when WDR97 is activated, it can cause the translation of certain genes into proteins. This is important because the production of certain proteins is regulated by RNA molecules, and WDR97 has been shown to play a role in this process.

WDR97 has also been shown to have potential as a drug target. Its unique structure and function make it an attractive target for researchers to study. Researchers are currently working to identify small molecules that can inhibit the activity of WDR97 and prevent it from functioning as a drug target. These small molecules may have potential as new treatments for a variety of diseases.

In addition to its potential as a drug target, WDR97 has also been shown to have potential as a biomarker. Its unique structure and function make it an attractive target for researchers to study. Researchers are currently working to identify biomarkers that can be used to diagnose or monitor the progression of certain diseases. These biomarkers may have potential as new diagnostic tests or monitoring tools for a variety of diseases.

Overall, WDR97 is a non-coding RNA molecule that has a unique structure and function. Its potential as a drug target and biomarker make it an attractive target for researchers to study. Further research is needed to fully understand its role in the regulation of various physiological processes in the body.

Protein Name: WD Repeat Domain 97

The "WDR97 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about WDR97 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets